Oncology immunotherapy

Checkpoint inhibitors, CAR-T, bispecifics across mechanistic and clinical research.

Immunotherapy is one of the fastest-moving subfields of oncology. New checkpoint combinations, CAR-T variants, TCR engineering, and bispecific antibodies reach trial monthly. Relaylit tracks PubMed, Europe PMC, and arXiv (for bioinformatics/ML methods) in one weekly digest.

Example brief

"Checkpoint inhibitor combinations and CAR-T therapies in solid tumours, with mechanistic and clinical trial papers. Include preprints."

Paste this into your Relaylit profile and tweak. First digest arrives within hours.

Where Relaylit searches for this topic

PubMed

35M+ biomedical citations from MEDLINE, life-science journals, and online books.

About PubMed →

Europe PMC

42M+ life science citations, including preprints and full-text open-access papers.

About Europe PMC →

Semantic Scholar

200M+ academic papers with citation graphs and AI-extracted metadata across disciplines.

About Semantic Scholar →

Crossref

155M+ records covering journals, conference proceedings, books, and preprints with DOIs.

About Crossref →

How Relaylit tracks oncology immunotherapy

1. Describe it once

Paste a plain-language brief for oncology immunotherapy. No boolean operators, no saved-search syntax.

2. We search 4 databases

Relaylit queries PubMed, Europe PMC, Semantic Scholar and Crossref on the live APIs, deduplicates the results, and ranks each paper against your brief.

3. Read the digest

A focused, ranked email lands weekly, biweekly, or monthly — the strongest oncology immunotherapy work, not a raw feed.

Frequently asked questions

Which research databases does Relaylit search for oncology immunotherapy?

Relaylit searches PubMed, Europe PMC, Semantic Scholar and Crossref for oncology immunotherapy. Every result is pulled from the live APIs each time your digest is generated, so new work reaches you within hours of being indexed.

How often will I get oncology immunotherapy updates?

You choose the cadence — weekly, biweekly, or monthly. Each digest ranks every new match against your brief and emails you a focused, ranked selection instead of a raw feed.

Can I customise what counts as relevant?

Yes. You write a plain-language brief — for example: "Checkpoint inhibitor combinations and CAR-T therapies in solid tumours, with mechanistic and clinical trial papers. Include preprints." — and Relaylit ranks every result against it. Tighten or broaden the brief any time.

Is tracking oncology immunotherapy free?

Relaylit is free for up to two topics, so you can track oncology immunotherapy at no cost. Paid plans add more topics and higher frequency.

Ready to track this?

Your first oncology immunotherapy digest lands this week.

Start free